Le notizie dalla Borsa Italiana del adaptive-biotechnologies-and-collaborators-to-present-more-than-30-abstracts-demonstrating-the-actionability-of-clonoseq-mrd-testing-in-blood-cancer-patient-care-and-drug-development-at-the-65th-ash-annual-meeting-1736303


Condividi